Overview
RGEN market data
Price History
RGEN price chart · 1M
- O
- 167.83
- H
- 169.32
- L
- 165.37
- C
- 167.53
- Vol
- 56,898.00
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $167.83
- Previous Close
- $169.60
- Day High
- $169.32
- Day Low
- $165.37
- 52 Week High
- $188.55
- 52 Week Low
- $101.00
- 7 Day Return
- -4.94%
- 30 Day Return
- +5.55%
- 90 Day Return
- +33.74%
- 1 Year Return
- +40.43%
- Daily Notional Volume
- $9.5M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- 229.65 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $0.86 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.14 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 5.3% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $100.99 – $188.73 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $9.5B · P/B 4.38 · P/S 12.15.
Company News
10 captured
Novartis' Remibrutinib Delivers Positive Results in Late-Stage MS StudiesZacks Investment Research ·
8-K filing — REPLIGEN CORP (RGEN)SEC EDGAR ·